Congenital dyserythropoietic anemia type II: Molecular basis and clinical aspects

Haematologica

Volumn 81, Issue 6, 1996, Pages 543-559

  Iolascon, Achille ^a   D'Agostaro, Giacomo ^b   Perrotta, Silverio ^c   Izzo, Pietro ^a   Tavano, Rosa ^a   Miraglia Del Giudice, Emanuele ^c  

^a UNIVERSITY OF BARI   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Anion exchange transporter; Bone marrow; CDA II; Congenital dyserythropoietic anemia type II; Dyserythropoiesis; Glycosylation; HEMPAS

Indexed keywords

ANION EXCHANGE; DNA SEQUENCE; GLYCOSYLATION; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; JAUNDICE; REVIEW; SPLENOMEGALY;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; CARBOHYDRATE SEQUENCE; CHROMOSOME MAPPING; GENETIC MARKERS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES;

EID: 0030321625     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 1968; 34:103-12.
2. Crookston JH, Crookston MC, Burnie KL, Francombe WH, Dacie JV, Lewis SM. Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol 1969; 17:11-23.
3. Morks W M, Mitus J. Congenital dyserythropoietic anemias. Am J Hematol 1996; 51:55-63.
4. Fukuda MN. HEMPAS disease: genetic defect of glycosylation. Glycobiology 1990; 1:9-15.
5. Fukuda MN. Congenital dyserythropoietic anemia type II (HEMPAS) and its molecular basis. Clin Haematol 1993; 6:493-511.
6. Ham TH. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. A study of the mechanism of hemolysis in relation to acid-base equilibrium. N Engl J Med 1937; 217:915-23.
7. Anselstetter V, Horstmann HJ, Heimpel H. Congenital dyserythropoietic anaemia, type I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis. Br J Haematol 1977; 35:209-17.
8. Palek J, Jarolim P. Clinical expression and laboratory detection of red cell membrane protein mutations. Semin Hematol 1993; 30:249-83.
9. Bennett V, Gilligan DM. The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane. Annu Rev Cell Biol 1993; 9:27-66.
10. Tanner MJA. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol 1993; 30:34-57.
11. Casey JR, Reithmeier AF. Analysis of the oligomeric state of band 3, the anion transport protein of the human erythrocyte membrane, by size exclusion high performance liquid chromatography. Oligomeric stability and origin of heterogeneity. J Biol Chem 1991; 266:15726-37.
12. Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RI, Lux SE Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia: Lippincott Company, 1995:1701-818.
13. Verwilghen RL, Lewis SM, Dacie JV, Crookston JH, Crookston MC. HEMPAS: congenital dyserythropoietic anaemia (type II). Q J Med 1973; 42:257-78.
14. Barosi G, Cazzola M, Stefanelli M, Ascari E. Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol 1979; 43:243-50.
15. Vuillez JP, Molina L, Bachelot C, Bost M, Hollard D. Dysérythropoiése congénitale. Presse Méd 1993; 22:1709.
16. McCann SR, Firth R, Murray N, Temperley IJ. Congenital dyserythropoietic anaemia type II (HEMPAS): a family study. J Clin Pathol 1980; 33:1197-201.
17. Sondag D, Weill JP, Oberling F. Anemie par dysérythropoiése congénitale: type II (hempas). Intéret de la splénectomie. Nouv Presse Méd 1982; 11:2419-21.
18. Lowenthal RM, Marsden KA, DewarCL, Thompson GR. Congenital dyserythropoietic anaemia (CDA) with severe gout, rare Kell phenotype and erythrocyte, granulocyte and platelet membrane reduplication: a new variant of CDA type II. Br J Haematol 1980; 44:211-20.
19. Vermylen C , Scheiff JM, Rodhain J, Ninane J, Cornu G. A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic series. Eur J Haematol 1986; 145:232-5.
20. Faruqui S, Abraham A, Berenfeld MR, Gabuzda TG. Normal serum ferritin levels in a patient with HEMPAS syndrome and iron overload. Am J Clin Pathol 1982; 78:97-101.
21. Cazzola M, Barosi G, Betgamaschi G, et al. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol 1983; 54:649-54.
22. Halpern Z, Rahmani R, Levo Y. Severe Hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. Acta Haematol 1985; 74:178-80.
23. Bird AR, Jacobs P, Moores P. Congenital dyserythropoietic anaemia (type II) presenting with haemosiderosis. Acta Haematol 1987; 78:33-6.
24. Greiner TC, Burns CP, Dick FR, Henry KM, Mahmood I. Congenital dyserythropoietic anemia type II diagnosed in a 69 year old patient with iron overload. Am J Clin Pathol 1992; 98:522-5.
25. West NC, Meigh RE, Mackie M, Anderson MJ. Parvovirus infection associated with aplastic crisis in a patient with HEMPAS. J Clin Pathol 1986; 39:1019-20.
26. Fukuda MN, Gaetani GF, Izzo P, Scartezzini P, Dell A. Incompletely processed N- glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS). Br J Haematol 1992; 82:745-52.
27. Lugassy G, Michaeli J, Harats N, Libson E, Rachmilewitz EA. Paravertebral extramedullary hematopoiesis associated with improvement of anemia in congenital dyserythropoietic anemia type II. Am J Hematol 1986; 22:295-300.
28. Nozawa S, Yajima M, Sakuma T, et al. Cancer associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma. Cancer Res 1990; 50:754-9.
29. Crookston JH, Crookston MC, Rosse WF. Red cell abnormalities in HEMPAS (hereditary erythroblastic multinuclearity with a positive acidified-serum test). Br J Haematol 1983; 23:83-94.
30. Wong KY, Hug G, Lampkin BC. Congenital dyserythropoietic anemia type II. Ultrastructural and radioautographic studies of blood and bone marrow. Blood 1972; 39:23-30.
31. Fresco R. Electron microscopy in the diagnosis of the bone marrow disorders of the erythroid series. Semin Hematol 1981; 18:279-92.
32. Fukuda MN, Klier G, Scartezzini P. Congenital dyserythropoietic anaemia type II (HEMPAS): characterization of aberrant intracellular organelles by immunogold electron microscopy. Br J Haematol 1987; 67:95-101.
33. Rosse WF. Dr. Ham's test revisited. Blood 1991; 78:547-9.
34. Tomita A, Porter CJ. Aberrant regulation of complement by the erythrocytes of hereditary erythroblastic multinuclearity with a positive acidified serum lysis test (HEMPAS). Blood 1994; 83:250-9.
35. Baines AJ, Banga JPS, Gratzer WB, Linch DC, Evehns ER. Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMPAS). Br J Haematol 1982; 50:563-71.
36. Alloisio N, Jaccoud P, Dorleac E, et al. Alterations of globin chain synthesis and of red cell membrane proteins in congenital dyserythropoietic anaemia I and II. Pediatr Res 1982; 16:1016-25.
37. Scartezzini P, Forni GL, Boldi M, Izzo C, Sansone G. Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II. Br J Haematol 1982; 51:569-74.
38. Mawby WJ, Tanner MJA, Anstee DJ, Clamp JR. Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (CDA II). Br J Haematol 1983; 55:357-67.
39. Fukuda MN, Papayannopoulou T, Gordon-Smith EC, Bochart H, Testa U. Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (HEMPAS). Br J Haematol 1984; 56:55-61.
40. Bouhours JF, Bouhours D, Delaunay J. Abnormal fatty acid composition of erythrocyte glycosphingolipids in congenital dyserythropoietic anemia type II. J Lipids Res 1985; 26:435-42.
41. Miraglia del Giudice E, Perrotta S, Pinto L, et al. Hereditary spherocytosis characterized by increased spectrin/band 3 ratio. Br J Haematol 1992; 80:133-5.
42. Alloisio N, Texier P, Denoroy L, et al. The cisternae decorating the red cell membrane in congenital dyserythropietic anemia (type II) originate from the endoplasmic reticulum. Blood 1996 (in press).
43. Ting J, Lee AS. Human gene encoding the 78,000-dalton glucose-regulated protein and its pseudogene: structure, conservation and regulation. DNA 1988; 7:275-86.
44. Rokeach LA, Haselby JA, Meilof JF, et al. Characterization of the autoantigen calreticulin. J Immunol 1991; 147:3031-40.
45. Fukuda MN, Klier G, Yu J, Scartezzini P. Anomalous clustering of underglycosylated Band 3 in erythricytes and their precursor cells in congenital dyserythropoietic anemia type II. Blood 1986, 68:521-9.
46. Reitman ML, Varki A, Kornfeld S. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5′-phopshate-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase activity. J Clin Invest 1981; 67:1574-9.
47. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localized N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994, 71:123-7.
48. Charuk JHM, Tan J, Bernardini M, et al. Carbohydrate-deficient glycoprotein syndrome type II: an autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS). Eur J Biochem 1995; 230:797-805.
49. Ioffe E, Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc Natl Acad Sci USA 1994; 91:728-32.
50. Metzler M, Gertz A, Sarkar M, Schachter H, Schrader JW, Marth JD. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J 1994; 13:2056-65.
51. Varki A, Hooshmand F, Diaz S, Varki NM, Hedrick SM. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell 1991; 66:65-74.
52. Hirschberg CB, Snyder MD. Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Ann Rev Biochem 1987; 56:61-87.
53. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985; 54:631-64.
54. Trombetta SE, Parodi AJ. Purification to apparent homogeneity and partial characterization of rat liver UDP-glucose: glycoprotein glucosyltransferase. J Biol Chem 1992; 267:9236-40.
55. Ou W-J, Cameron PH, Thomas DY, Bergeron JJM. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 1993; 364:771-6.
56. Hebert DN, Foellmer B, Helenius A. Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 1995; 81:425-33.
57. Otteken A, Moss B. Calreticulin interacts with newly synthesized human immunodeficiency virus type I envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. J Biol Chem 1996; 271:97-103.
58. Nauseef WN, McCrmick S, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 1995; 270:4741-7.
59. Daniel PF, Winchester B, Warren CD. Mammalian α-mannosidases-multiple forms but a common purpose? Glycobiology 1994; 4:551-66.
60. Moremen KW, Trimble RB, Herscovics A. Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology 1994; 4:113-25.
61. Paulson JC, Colley KJ. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 1989; 264:17615-8.
62. Stanley P. Glycosylation mutants of animal cells. Ann Rev Genet 1984; 18:525-52.
63. Schachter H, Narasimhan S, Gleeson P, Vella G. Control of branching during the biosynthesis of asparagine-linked oligosaccharides. Can J Biochem Cell Biol 1983; 61:1049-66.
64. Bendiak B, Schachter H. Control of glycoprotein synthesis. Purification of UDP-N-Acetylglucosamine: α-D-mannoside β1-2 N-acetylglucosaminyltransferase II from rat liver. J Biol Chem 1987; 262:5775-83.
65. D'Agostaro G, Bendiak B, Tropak M. Cloning of cDNA encoding the membrane-bound form of β-1,4-galactosyltransferase. Eur J Biochem 1989; 183:211-7.
66. Teasdale RJ, D'Agostaro G, Gleeson PA. The signal for Golgi retention of bovine β1,4-galactosyltransferase is in the transmembrane domain. J Biol Chem 1992; 267:4084-96.
67. Fukuda M, Dell A, Oates JE, Fukuda MN. Structure of branched lactosoaminoglycan, the carbohydrate moiety of band 3 isolated from adult human erythrocytes. J Biol Chem 1984b; 259:8260-73.
68. Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC. Structure of sialylated fucosyl lactosoaminoglycans isolated from human granulocytes. J Biol Chem 1984c; 259:10925-35.
69. Childs RA, Dalchau R, Scudder P, Hounsell EP, Fabre JW, Feizi T. Evidence for the occurrence of O-glycosidically linked oligosaccharides of poly-N-acetyllactosamine type of the human leukocyte common antigen.. Biochem Biophys Res Comm 1983; 110:424-31.
70. Fukuda M, Dell A, Fukuda MN. Structure of fetal lactosaminoglycans. The carbohydrate moiety of Band 3 isolated from human umbilical cord erythrocytes. J Biol Chem 1984a; 259:4782-91.
71. Spooncer E, Fukuda M, Klock JC, Oates JE, Dell A. Isolation and characterization of polyfucosylated lactosaminoglycan from human ganulocytes. J Biol Chem 1984; 259:4792-801.
72. Feizi T. Demonstration by monoclonal antibodies that carbohydrat structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985; 314:53-7.
73. Cummings RD, Trowbridge IS, Kornfeld S. A mouse lymphoma cell line resistant to the leucoagglutinating lectin from Phaseolus Vulgaris is deficient in UDP-GlcNAc: α-D-mannoside β1→6N-acetylglucosaminyltransferase. J Biol Chem 1982; 257:13421-7.
74. van den Eijnden DH, Koenderman AHL, Schiphorst WECM. Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNac:N-acetyllactosaminide β1→3-N acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid. J Biol Chem 1988; 263:12461-71.
75. Do K-Y, Cummings RD. 2,6-branched mannose and the regulation of poly-N-acetyllactosamine biosynthesis in N-linked oligosaccharides of Chinese hamster ovary cells. J Biol Chem 1993; 268:22028-35.
76. Fukuda MN, Dell A, Scartezzini P. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. J Biol Chem 1987a; 262:7195-206.
77. Fukuda MN, Masri KA, Dell A, Thonar EJ, Klier G, Lowenthal RM. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase. Blood 1989; 73:1331-9.
78. Fukuda MN, Gaetani GF, Izzo P, Scartezzini P, Dell A. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS). Br J Haematol 1992; 82:745-52.
79. Petrarca C, Bendiak B, D'Agostaro G. Genomic mapping of the rat UDP-N-Acetylglucosamine: α-6-D-mannoside-β-1,2-N-Acetyl glucosaminyltransferase II gene. Glycoconjugate J 1993; 10:234.
80. D'Agostaro G, Zingoni A, Schacter H, Moritz RL, Simpson RJ, Bendiak B. Molecular cloning and expression of cDNA encoding the rat UDP-N-Acetylglucosamine: α-6-D-mannoside β-1,2-N-acetylglucosaminyltransferase II. J Biol Chem 1995; 270:15211-21.
81. Tan J, D'Agostaro GAF, Bendiak B, et al. The human UDP-N-acetylglucosamine: α-6-D-mannoside-β-1,2-N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein. Eur J Biochem 1995; 231:317-28.
82. Moremen K.W, Robbins PW. Isolation, characterization, and expression of cDNAs encoding murine α-mannosidase II, a Golgi enzyme that control conversion of high mannose to complex N-glycans. Cell Biol 1991; 115:1521-34.
83. Misago M, Liao Y-F, Kudo S, et al. Molecular cloning and expression of cDNAs encoding human α-mannosidase II and a previously unrecognized α-mannosidase IIx isozyme. Proc Natl Acad Sci USA 1995; 92:11766-70.
84. Curtis D, Lehmann R, Zamore PD. Translational regulation in development. Cell 1995; 81:171-8.
85. Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell 1995; 81:179-83.
86. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995; 80: 58-68.